649 related articles for article (PubMed ID: 1971016)
1. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
Carter CJ; Lloyd KG; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
[TBL] [Abstract][Full Text] [Related]
2. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
3. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
[TBL] [Abstract][Full Text] [Related]
4. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Enomoto R
J Pharmacol Exp Ther; 1991 Mar; 256(3):1161-72. PubMed ID: 1826032
[TBL] [Abstract][Full Text] [Related]
5. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons.
Tamura Y; Sato Y; Yokota T; Akaike A; Sasa M; Takaori S
J Pharmacol Exp Ther; 1993 May; 265(2):1017-25. PubMed ID: 8098757
[TBL] [Abstract][Full Text] [Related]
6. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.
Gotti B; Duverger D; Bertin J; Carter C; Dupont R; Frost J; Gaudilliere B; MacKenzie ET; Rousseau J; Scatton B
J Pharmacol Exp Ther; 1988 Dec; 247(3):1211-21. PubMed ID: 2849668
[TBL] [Abstract][Full Text] [Related]
7. Effects of ifenprodil on the N-methyl-D-aspartate receptor ionophore complex in rat brain.
Ogita K; Ohkawara A; Suzuki T; Ohgaki T; Uchida S; Meguri H; Yoneda Y
Neurochem Int; 1992 Jul; 21(1):135-47. PubMed ID: 1363860
[TBL] [Abstract][Full Text] [Related]
8. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
Berger ML; Rebernik P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
[TBL] [Abstract][Full Text] [Related]
9. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines.
Subramaniam S; McGonigle P
J Pharmacol Exp Ther; 1991 Feb; 256(2):811-9. PubMed ID: 1671602
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques.
Yoneda Y; Ogita K
J Pharmacol Exp Ther; 1991 Oct; 259(1):86-96. PubMed ID: 1681092
[TBL] [Abstract][Full Text] [Related]
11. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
Sharma TA; Reynolds IJ
J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
[TBL] [Abstract][Full Text] [Related]
13. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of the associated glycine recognition site by competitive N-methyl-D-aspartate receptor antagonists.
Monahan JB; Biesterfeldt JP; Hood WF; Compton RP; Cordi AA; Vazquez MI; Lanthorn TH; Wood PL
Mol Pharmacol; 1990 Jun; 37(6):780-4. PubMed ID: 2163012
[TBL] [Abstract][Full Text] [Related]
15. Polyamines regulate glycine interaction with the N-methyl-D-aspartate receptor.
Ransom RW; Deschenes NL
Synapse; 1990; 5(4):294-8. PubMed ID: 1972818
[TBL] [Abstract][Full Text] [Related]
16. Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.
Lester RA; Quarum ML; Parker JD; Weber E; Jahr CE
Mol Pharmacol; 1989 May; 35(5):565-70. PubMed ID: 2566902
[TBL] [Abstract][Full Text] [Related]
17. Histamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding site.
Burban A; Faucard R; Armand V; Bayard C; Vorobjev V; Arrang JM
J Pharmacol Exp Ther; 2010 Mar; 332(3):912-21. PubMed ID: 20008958
[TBL] [Abstract][Full Text] [Related]
18. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
[TBL] [Abstract][Full Text] [Related]
19. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
Coughenour LL; Barr BM
J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
[TBL] [Abstract][Full Text] [Related]
20. Evidence that zinc inhibits N-methyl-D-aspartate receptor-gated ion channel activation by noncompetitive antagonism of glycine binding.
Yeh GC; Bonhaus DW; McNamara JO
Mol Pharmacol; 1990 Jul; 38(1):14-9. PubMed ID: 1695316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
